Haima Therapeutics, LLC
is a pre-clinical stage biotechnology company focused on developing bio-inspired
therapies for treatment of bleeding and other blood-related ailments.
SynthoPlatE
is a novel nanoparticle-based synthetic platelet technology that can stop bleeding quickly
by mimicking and amplifying your body's natural clotting mechanisms. LEARN MORE
